Paul Tudor Jones’s Replimune Group REPL Stock Holding History

Paul Tudor Jones’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-631,900	Closed	-$4.83M	–	4156
2026 Q1	$4.83M	Buy	631,900 +594,000	+1,567%	+$4.54M	0.01%	1188
2025 Q4	$368K	Buy	+37,900	New	+$322K	﹤0.01%	2915

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Paul Tudor Jones's REPL Position: Q1 2026 in Review

Paul Tudor Jones sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 128,380 shares — an estimated $981K sold.

Paul Tudor Jones first reported a position in REPL in Q1 2022 and held it in 11 quarters. The position peaked at $1.25M in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

Paul Tudor Jones reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
Paul Tudor Jones sold 128,380 Replimune Group shares in Q1 2026, an estimated $981K.
Paul Tudor Jones first reported a position in Replimune Group in Q1 2022 and held it in 11 quarters.
Paul Tudor Jones's Replimune Group position peaked at $1.25M in Q4 2025.
180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.